Accolade, Inc.
ACCD US
ACCD USAccolade, Inc.
United States CompositeCompany Description
- CEO
- Mr. Rajeev Singh
- Full Time Employees
- 2,370
- Sector
- Healthcare
- Industry
- Health Information Services
- Address
- 660 West Germantown Pike Plymouth Meeting PA United States 19462
- Website
- www.accolade.com
- Business
- Accolade, Inc., together with its subsidiaries, engages in the development and provision of personalized and technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women's health specialists, case management specialists, expert medical opinion providers, and virtual primary care physicians. It also provides medical opinion and decision support services; and technology and administrative services to the medical practice PCs providing virtual primary care services. The company serves employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was incorporated in 2007 and is headquartered in Seattle, Washington.
Company News
Accolade, Inc. (NASDAQ:ACCD) Q4 2024 Earnings Call Transcript
Accolade, Inc. (NASDAQ:ACCD) Q4 2024 Earnings Call Transcript
Analysts Offer Insights on Healthcare Companies: AstraZeneca (AZN), Accolade (ACCD) and Morphic Holding (MORF)
Analysts Offer Insights on Healthcare Companies: AstraZeneca (AZN), Accolade (ACCD) and Morphic Holding (MORF)
Analysts Offer Insights on Healthcare Companies: Accolade (ACCD), Vertex Pharmaceuticals (VRTX) and Zimmer Biomet Holdings (ZBH)
Analysts Offer Insights on Healthcare Companies: Accolade (ACCD), Vertex Pharmaceuticals (VRTX) and Zimmer Biomet Holdings (ZBH)
Accolade, Inc. at a Crossroads: Navigating Regulatory Risks in AI Integration
Accolade, Inc. at a Crossroads: Navigating Regulatory Risks in AI Integration
Why Aon Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Why Aon Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Analysts Are Bullish on These Healthcare Stocks: Accolade (ACCD), PROCEPT BioRobotics (PRCT)
Analysts Are Bullish on These Healthcare Stocks: Accolade (ACCD), PROCEPT BioRobotics (PRCT)
Q4 2024 Accolade Inc Earnings Call
Q4 2024 Accolade Inc Earnings Call
Analysts Are Bullish on Top Healthcare Stocks: Accolade (ACCD), Resmed (RMD)
Analysts Are Bullish on Top Healthcare Stocks: Accolade (ACCD), Resmed (RMD)
Accolade’s Hold Rating Affirmed Amid Revenue Growth Uncertainty and Earnings Volatility
Accolade’s Hold Rating Affirmed Amid Revenue Growth Uncertainty and Earnings Volatility
Accolade Inc (ACCD) Q4 2024 Earnings Call Transcript Highlights: Record Revenue and Strategic ...
Accolade Inc (ACCD) Q4 2024 Earnings Call Transcript Highlights: Record Revenue and Strategic ...